| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | Chief Medical Officer | Common Stock | 258K | $4.12M | $15.93 | Feb 14, 2022 | Direct |
| Tourmaline Bio, Inc. | Chief Medical Officer | Common Stock | 56.8K | $966K | $16.99 | Oct 19, 2023 | Direct |
| Keros Therapeutics, Inc. | Chief Medical Officer | Employee Stock Option (right to buy) | 110K | Nov 8, 2024 | Direct | ||
| Tourmaline Bio, Inc. | Chief Medical Officer | Employee Stock Option (Right to Buy) | 73.2K | Oct 23, 2023 | Direct | ||
| Scholar Rock Holding Corp | Chief Medical Officer | Stock Option (Right to Buy) | 37.5K | Feb 14, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | Nov 8, 2024 | 1 | $0 | 4 | Nov 12, 2024 | Chief Medical Officer |
| KROS | Keros Therapeutics, Inc. | Nov 1, 2024 | 0 | $0 | 3 | Nov 8, 2024 | Chief Medical Officer |
| TALS | Tourmaline Bio, Inc. | Oct 19, 2023 | 3 | $0 | 4 | Oct 23, 2023 | Chief Medical Officer |
| TALS | Tourmaline Bio, Inc. | Oct 19, 2023 | 0 | $0 | 3 | Oct 23, 2023 | Chief Medical Officer |
| SRRK | Scholar Rock Holding Corp | Feb 14, 2022 | 2 | $0 | 4 | Feb 15, 2022 | Chief Medical Officer |
| SRRK | Scholar Rock Holding Corp | Jan 15, 2022 | 1 | -$27.7K | 4 | Jan 19, 2022 | Chief Medical Officer |